» Authors » Spyros Peppas

Spyros Peppas

Explore the profile of Spyros Peppas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Figlioli G, Piovani D, Peppas S, Pugliese N, Hassan C, Repici A, et al.
Pharmacol Res . 2024 Nov; 210:107482. PMID: 39490913
No abstract available.
2.
Figlioli G, Piovani D, Peppas S, Pugliese N, Hassan C, Repici A, et al.
Pharmacol Res . 2024 Sep; 208:107401. PMID: 39251099
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used for glucose lowering and weight-loss. However, their association with gastrointestinal cancer remains uncertain. This meta-analysis assesses the risk of gastrointestinal...
3.
Peppas S, Doumas S, Suvarnakar A, Chou J, Arafat A, Ahmad A, et al.
Eur J Gastroenterol Hepatol . 2024 Mar; 36(5):674-682. PMID: 38477839
Background: Previous studies have demonstrated a beneficial effect of metformin in patients with cirrhosis, but no improvement in liver histology. Aim: To investigate the impact of metformin on mortality and...
4.
Ahmad A, Lee A, Nithagon P, Ayaz O, Altork N, Peppas S, et al.
JGH Open . 2023 Nov; 7(10):674-681. PMID: 37908288
Background And Aim: Esophageal squamous papilloma (ESP) is a benign growth in the esophagus with unknown malignant potential. The mechanism underlying ESP formation is unknown, but human papillomavirus (HPV) infection...
5.
Peppas S, Ahmad A, Altork N, Cho W
Surg Endosc . 2023 Jul; 37(9):6695-6703. PMID: 37479838
Background: Post-lung transplant gastroparesis is a frequent debilitating complication of lung transplant recipients, as it can increase the risk for gastro-esophageal reflux disease and subsequent graft dysfunction. We performed a...
6.
Peppas S, Palaiodimos L, Nagraj S, Kokkinidis D, Tiwari N, Kharawala A, et al.
Healthcare (Basel) . 2023 May; 11(10). PMID: 37239692
Objective: The aim of this study was to assess the association between the presence of a right-to-left shunt (RLS) and neurological decompression sickness (NDCS) and asymptomatic brain lesions among otherwise...
7.
Nagraj S, Varrias D, Kharawala A, Mathai S, Seo J, Narvel H, et al.
Cardiovasc Diagn Ther . 2023 Mar; 13(1):1-10. PMID: 36864966
Background: Ethnic and sex-based disparity in outcomes after out-of-hospital cardiac arrest (OHCA) may exist and could be due to social factors and inequality in care. We aimed to study whether...
8.
Archontakis Barakakis P, Kokkinidis D, Li W, Nagraj S, Peppas S, Kladas M, et al.
J Clin Gastroenterol . 2023 Feb; 57(10):1045-1053. PMID: 36730651
Goals And Background: Since the introduction of Direct Oral Anticoagulants (DOACs), "real-world" studies have investigated their safety profile on gastrointestinal hemorrhage (GIH) when used by patients with Non-Valvular Atrial Fibrillation....
9.
Nagraj S, Peppas S, Rubianes Guerrero M, Kokkinidis D, Contreras-Yametti F, Murthy S, et al.
World J Transplant . 2022 Sep; 12(7):142-156. PMID: 36051452
Cardiovascular diseases (CVD) form a principal consideration in patients with end-stage liver disease (ESLD) undergoing evaluation for liver transplant (LT) with prognostic implications in the peri- and post-transplant periods. As...
10.
Peppas S, Nagraj S, Koutsias G, Kladas M, Archontakis-Barakakis P, Schizas D, et al.
Heart Lung Circ . 2022 Jun; 31(9):1191-1202. PMID: 35667970
Portopulmonary hypertension is defined as the development of pulmonary arterial hypertension in the setting of portal hypertension with or without liver cirrhosis. Portal hypertension-associated haemodynamic changes, including hyperdynamic state, portosystemic...